TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

First Page		Document Content
Health economics Healthcare quality Immunosuppressants Orphan drugs Costs Disease-modifying antirheumatic drug Tocilizumab Rituximab Quality-adjusted life year Rheumatoid arthritis Etanercept TNF inhibitor		TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS Add to Reading List Source URL: www.nicedsu.org.uk Download Document from Source Website File Size: 229,84 KB Share Document on Facebook

	CLINICAL TRIAL OUTCOME DATABASE (CTOD) Novartis RA: Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development Authors I Demin, B Hamren, O Luttringer, G Pillai and DocID: 1vbDv - View Document
	Autoimmune Th17 cells induced synovial stromal and innate lymphoid cell secretion of the cytokine GM-CSF to initiate and augment autoimmune arthritis Keywords: rheumatoid arthritis, autoimmune disease, GM-CSF, Th17, infl DocID: 1uFrU - View Document
	Nanofluidic Implants for Better Health: More precise administration of drugs and hormones is needed to better treat chronic pathologies including diabetes, cancer, rheumatoid arthritis, HIV PrEP and others. A team led b DocID: 1uwix - View Document
	巴斯德讲坛-大师系列 Pasteur Colloquium-Master Autoimmune priming, tissue attack and chronic inflammation – the three stages of rheumatoid arthritis DocID: 1tRy7 - View Document
	Studies of disease pathways and potential drug targets in chronic inflammatory diseases Chronic inflammatory diseases, like Rheumatoid Arthritis (inflammation in joints) and Multiple Sclerosis (inflammation in CNS), are DocID: 1sllq - View Document